LENZ Therapeutics, Inc.LENZNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank50
3Y CAGR+5.1%
5Y CAGR+21.9%
Year-over-Year Change
Research and development spending
3Y CAGR
+5.1%/yr
Annual compound
5Y CAGR
+21.9%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
2.7x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.54M | -17.7% |
| 2024 | $29.80M | -49.9% |
| 2023 | $59.50M | +181.7% |
| 2022 | $21.13M | -44.3% |
| 2021 | $37.93M | +315.8% |
| 2020 | $9.12M | - |
| 2019 | $0.00 | - |